Détail de l'auteur
Documents disponibles écrits par cet auteur (32)
trié(s) par (Pertinence décroissant(e), Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) | Mettre toutes les notices dans le panier | Faire une suggestion | Ajouter un critère de recherche
Muscle involvement in myasthenia gravis: Expanding the clinical spectrum of myasthenia-myositis association from a large cohort of patients
Garibaldi M, Fionda L, Vanoli F, et al.
Autoimmunity reviews, 2020
Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial
Hanna MG, Badrising UA, Benveniste O, et al.
The Lancet. Neurology, 2019, 18, 9, p 834
A phase 3 randomized study evaluating sialic acid extended-release for GNE myopathy.
Lochmuller H, Behin A, Caraco Y, et al.
Neurology, 2019, 92, n18, e2109-e2117
Muscle Resonance Imaging pattern recognition in sporadic Inclusion Body Myositis.
Tasca G, Monforte M, De Fino C, et al.
Muscle & Nerve, 2015, 52, 6, p. 956-62
Hereditary inclusion-body myopathies
Broccolini A, Mirabella M
Biochimica et biophysica acta, 2015, 1852, 4, p 644
Atrophy, fibrosis, and increased PAX7-positive cells in pharyngeal muscles of oculopharyngeal muscular dystrophy patients
Gidaro T, Negroni E, Périé S, et al.
Journal of neuropathology and experimental neurology, 2013, 72, 3, p. 234-243
Atrophy, fibrosis, and increased PAX7-positive cells in pharyngeal muscles of oculopharyngeal muscular dystrophy patients
Gidaro T, Negroni E, Périé S, et al.
Journal of neuropathology and experimental neurology, 2013, 72, 3, p 234
Muscle MRI in female carriers of dystrophinopathy
Tasca G, Monforte M, Iannaccone E, et al.
European journal of neurology, 2012, 19, 9, p. 1256-1260
Muscle imaging findings in GNE myopathy
Tasca G, Ricci E, Monforte M, et al.
Journal of neurology, 2012, 259, 7, p. 1358-1365
Hereditary inclusion-body myopathy with sparing of the quadriceps: the many tiles of an incomplete puzzle
Broccolini A, Gidaro T, Morosetti R, et al.
Acta myologica, 2011, 30, 2, p. 91-95
Mesoangioblasts from Facioscapulohumeral Muscular Dystrophy display in vivo a variable myogenic ability predictable by their in vitro behavior
Morosetti R, Gidaro T, Broccolini A, et al.
Cell transplantation, 2011, 20, 8, p. 1299-1313
Pilot trial of simvastatin in the treatment of sporadic inclusion-body myositis
Sancricca C, Mora M, Ricci E, et al.
Neurological sciences, 2011, 32, 5, p. 841-847
Increased aging in primary muscle cultures of sporadic inclusion-body myositis
Morosetti R, Broccolini A, Sancricca C, et al.
Neurobiology of aging, 2010, 31, 7, p. 1205-1214
Analysis of NCAM helps identify unusual phenotypes of hereditary inclusion-body myopathy
Broccolini A, Gidaro T, Tasca G, et al.
Neurology, 2010, 75, 3, p. 265-272
Hereditary inclusion-body myopathy : clues on pathogenesis and possible therapy
Broccolini A, Gidaro T, Morosetti R, et al.
Muscle & Nerve, 2009, 40, 3, p. 340-349
An Italian family with inclusion-body myopathy and frontotemporal dementia due to mutation in the VCP gene
Gidaro T, Modoni A, Sabatelli M, et al.
Muscle & Nerve, 2008, 37, 1, p. 111-114
Gene expression analysis in MRI positive FSHD muscles (Poster)
Collectif, Pescatori M, Tasca G, et al.
Neuromuscular disorders : NMD, 2008, 18, 9-10, p. 728
Partial caveolin 3 deficiency in acquired rippling muscle disease (Poster)
Collectif, Mirabella M, Charlton R, et al.
Neuromuscular disorders : NMD, 2008, 18, 9-10, p. 767
Transient overexpression of the Rho family exchange factor GEFT stimulates myogenic differentiation of inclusion-body myositis (IBM) mesoangioblasts (Poster)
Collectif, Morosetti R, Gliubizzi C, et al.
Neuromuscular disorders : NMD, 2008, 18, 9-10, p. 770
Gene expression profiling in the early phases of DMD : a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression
Pescatori M, Broccolini A, Minetti C, et al.
FASEB journal (The), 2007, 21, 4, p. 1210-1226
Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies
Morosetti R, Mirabella M, Gliubizzi C, et al.
Stem cells, 2007, 25, 12, p. 3173-3182
NCAM is hyposialylated in hereditary inclusion body myopathy due to GNE mutations
Ricci E, Broccolini A, Gidaro T, et al.
Neurology, 2006, 66, 5, p. 755-758
Reliability of the Hammersmith functional motor scale for spinal muscular atrophy in a multicentric study
Mercuri E, Messina S, Battini R, et al.
Neuromuscular disorders : NMD, 2006, 16, 2, p. 93-98
MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle
Morosetti R, Mirabella M, Gliubizzi C, et al.
Proceedings of the national Academy of sciences of the United States of America, 2006, 103, 45, p. 16995-17000
Pilot trial of phenylbutyrate in spinal muscular atrophy
Mercuri E, Bertini E, Messina S, et al.
Neuromuscular disorders : NMD, 2004, 14, 2, p. 130-135
